Pharmaceutical APIs
Afatinib
Active Pharmaceutical Ingredient — Neurology
Afatinib is an irreversible EGFR tyrosine kinase inhibitor used in treatment of metastatic non-small cell lung cancer with EGFR mutations.
- CAS Number
- 439081-18-2
- Therapeutic Area
- Neurology
- Drug Class
- Anticancer Agents
- Molecular Formula
- C24H25ClFN5O3
- Molecular Weight
- 485.94
- PubChem CID
- 10184653
RFQ / Inquiry
Request Afatinib
Send a structured RFQ to APINEXA's coordination team — confidential, supplier-matched, audit-grade. Typical response in 24 business hours.